Sara-Perlado-Marina

Sara Perlado Marina

Specialty:
Hematology and hemotherapy
Serving specialties:
  • Hematology and Hemotherapy
Hospitals where he/she works:
  • Hospital Universitario Fundación Jiménez Díaz
General Information
Experience

2020- Present: Associate Biologist in the Molecular Cytogenetics Laboratory, Hematology and Hemotherapy Service, Hospital Universitario Fundación Jiménez Díaz

2018-2020: Product Specialist in Next Generation Sequencing (NGS) (Genetics Area) in Diagnóstica Longwood.

2015-2017: Investigation Biologist in University Hospital of Donostia (Biodonostia) for the European investigation Project: ANGELAB.

2011-2014: Predoctoral Fellowship from Fundación Conchita Rábago de Jiménez Díaz . Thesis: "Approaching new fetal genetic diagnosis in maternal blood".

2010: Contract in the Genetics Laboratory of Fundación Jiménez Díaz in charge of the project "Molecular Basis of Congenital Malformations."

Degree

Bachelor of Biology (Universidad Autónoma de Madrid).

Master in Cellular Biology and Genetics. Universidad Autónoma de Madrid (UAM); Universidad Complutense de Madrid (UCM) y Universidad de Alcalá de Henares (UAH).

PhD in Molecular Biology. Project title: "Approaching new fetal genetic diagnosis in maternal blood"

Techniques

Conventional cytogenetics (karyotyping) of peripheral blood, bone marrow, lymph node, and biological fluid samples (pleural effusion, ascitic fluid, etc.)

Separation of CD138+ plasma cells for the study of multiple myeloma

Enrichment of granulocyte population for the study of eosinophilia

Fluorescence in situ hybridization (FISH) with probes for the study of hematological malignancies

Sanger sequencing

Massive sequencing: myeloid panel, lymphoid panel, and TP53 gene panel

Research and teaching

Thesis: "Approaching new fetal genetic diagnosis in maternal blood".

Teaching assistant for the Hematology course in the Medicine degree program at the Autonomous University of Madrid

Publications

Mireia Atance; Cristina Serrano; Carlos Soto; Juan Manuel Alonso-Domínguez; Carlos Blas; Raquel Mata; Tamara Castaño; Sara Perlado; Teresa Arquero; Jose Luis López-Lorenzo; M. Ángeles Pérez; Belen Rosado; Rafael Martos; Ana Rio-Machin; Pilar Llamas-Sillero; Rocio N. Salgado;Juana Serrano-López.2025. Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome.eJHaem

PERLADO S, BUSTAMANTE-ARAGONÉS, ANA, DONAS M, LORDA-SANCHEZ I, PLAZA J, RODRÍGUEZ DE ALBA M. Fetal Genotyping in Maternal Blood by Digital PCR: Towards NIPD of Monogenic Disorders Independently of Parental Origin. PLoS One. 2016 Apr 14; 11(4):e0153258.

BUSTAMANTE-ARAGONÉS, ANA, PERLADO-MARINA, SARA, TRUJILLO-TIEBAS MJ, GALLEGO-MERLO J, LORDA-SANCHEZ I, RODRIGUEZ-RAMIREZ L, LINARES C, HERNANDEZ C, DE ALBA MR. Non-Invasive Prenatal Diagnosis in the Management of Preimplantation Genetic Diagnosis Pregnancies. J Clin Med. 2014 Aug 14; 3(3):913-22. 11 •

PERLADO-MARINA, SARA; BUSTAMANTE-ARAGONÉS, ANA; HORCAJADA, LAURA; TRUJILLO-TIEBAS, MARIA JOSE; LORDA-SANCHEZ, ISABEL; RAMOS, MARTA RUIZ; PLAZA, JAVIER; DE ALBA, MARTA RODRIGUEZ. Overview of fiveyears experience performing non-invasive fetal sex assessment in maternal blood. Diagnostics. 2013 June; 3(2): 283-290.

RODRIGUEZ DE ALBA M, BUSTAMANTE-ARAGONÉS A, PERLADO S, TRUJILLOTIEBAS MJ, ARRANZ JP,DÍAZ-RECASENS J, TROYANO-LUQUE J, RAMOS C. Non-invasive prenatal diagnosis: present and future thanks to new technologies . Diagn Prenat. 2012 March; 23:67-75.

RODRÍGUEZ DE ALBA M, BUSTAMANTE-ARAGONÉS A, PERLADO S, TRUJILLOTIEBAS MJ, DÍAZ-RECASENS J, PLAZA-ARRANZ J, RAMOS C. Noninvasive prenatal diagnosis of monogenic disorders. Expert Opin Biol Ther. 2012 Jun; 12 Suppl 1:S171-9.

BUSTAMANTE-ARAGONÉS A, RODRÍGUEZ DE ALBA M, PERLADO S, TRUJILLOTIEBAS MJ, ARRANZ JP, DÍAZ-RECASENS J, TROYANO-LUQUE J, RAMOS C. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene. 2012 Aug; 504(1):144-9.

Communications and Presentations

Rocio Salgado; Mireia Atance; Sara Perlado; Teresa Arquero; Pilar LLamas; Ana Rio-Machin. Genetic and clinical analysis of patients diagnosed with myeloid neoplasia and germline mutations in DDX41. SEHH 2024. España.

Mireia Atance; Sara Perlado; Javier Sanchez; et al; Rocío Salgado. Tp53 events in multiple myeloma: deletion, mutation or both?. XI Simposio del GECGH 2023. España.

Mireia Atance Paarisas; Sara Perlado Marina; Carmen Carralero; et al; Rocío Salgado. Estudio De La Arquitectura Clonal De 29 Acute Myeloid Leukemias Secondary to Smd or Smd/mpN by Massive Sequencing . SEHH. 2021.

Ana Cerdá, Sara Perlado, Mireia Atance, Milagros Sanchez, Javier Sanchez, Carmen Carralero, Selene Ledesma, Laura Solan, Carlos Soto, Tamara Castaño, Carlos Blas, Juan Manuel Alonso-Dominguez, Pilar Llamas, Rocio Salgado. Acute Myeloid Leukemia with MYC gene amplification . VII Jornada Interhospitalaria de Genética en Hospital San Chinarro de Madrid.2022

Perlado,S, Atance,M, Rodruiguez-Pinilla SM, Serrano C, Manso R, Carvajal N, Blas C, Alonso-Dominguez JM, Sánchez M, Córdoba R, Piris MA, Llamas P, Salgado R." Advances in cytogenetic and molecular techniques in the diagnosis of malignant hematopathies: Redefining the diagnosis of aggressive B-cell lymphoma: Are we able to distinguish a real rearrangement of the MYC gene? VIII Simposio del GCECGH.2021

Awards and certifications

Member of the Spanish Society of Hematology and Hemotherapy (SEHH)

Member of the Spanish Association of Human Genetics (AEGH)